Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling.
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling. Cancer Res. 2014 Jun 15; 74(12):3294-305.
View in:
PubMed
subject areas
Acetamides
Aminopyridines
Aniline Compounds
Animals
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Drug Synergism
Feedback, Physiological
Female
Humans
MAP Kinase Kinase Kinases
Mice
Mice, Nude
Morpholines
Mutation
Protein Kinase Inhibitors
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
Pyrimidinones
Quinazolines
ras Proteins
Receptor, Fibroblast Growth Factor, Type 2
Signal Transduction
Sulfonamides
Tankyrases
Thiazoles
Xenograft Model Antitumor Assays
authors with profiles
Nika Danial, Ph.D.
William Raj Sellers, M.D.